Skip to Main Content

Amanda I. Adler, MD, PhD, and Nicholas Latimer, PhD, discuss adjusting for nonadherence or stopping treatments in randomized clinical trials.

This content feature is supported on the following browsers:
Firefox, Chrome, Internet Explorer 11, Safari 7 and newer